{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:27:27Z","timestamp":1792945647245,"version":"4.5.0"},"reference-count":235,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.idc.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:22:11Z","timestamp":1621300931000},"page":"279-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Resistance to Antifungal Drugs"],"prefix":"10.1016","volume":"35","author":[{"given":"Ronen","family":"Ben-Ami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib1","first-page":"57","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.idc.2021.03.003_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","article-title":"Mortality and costs of acute renal failure associated with amphotericin B therapy","volume":"32","author":"Bates","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib5","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.idc.2021.03.003_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib7","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib12","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/AAC.49.8.3171-3177.2005","article-title":"Fluconazole MIC and the fluconazole dose\/MIC ratio correlate with therapeutic response among patients with candidemia","volume":"49","author":"Clancy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib14","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1128\/AAC.00296-07","article-title":"Correlation of the MIC and dose\/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia","volume":"51","author":"Rodriguez-Tudela","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"1 Suppl","key":"10.1016\/j.idc.2021.03.003_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist Updat"},{"issue":"5\u20136","key":"10.1016\/j.idc.2021.03.003_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11046-014-9775-z","article-title":"Antifungal susceptibility profile of cryptic species of Aspergillus","volume":"178","author":"Alastruey-Izquierdo","year":"2014","journal-title":"Mycopathologia"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib19","doi-asserted-by":"crossref","first-page":"e1008519","DOI":"10.1371\/journal.ppat.1008519","article-title":"Short-term evolution strategies for host adaptation and drug escape in human fungal pathogens","volume":"16","author":"Beekman","year":"2020","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1534\/genetics.115.178020","article-title":"Parasexual ploidy reduction drives population heterogeneity through random and transient aneuploidy in Candida albicans","volume":"200","author":"Hickman","year":"2015","journal-title":"Genetics"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib21","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.00516-13","article-title":"Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals","volume":"57","author":"Yang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2021.03.003_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI124516","article-title":"Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis","volume":"129","author":"Stone","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.idc.2021.03.003_bib23","doi-asserted-by":"crossref","first-page":"e45954","DOI":"10.7554\/eLife.45954","article-title":"Genome plasticity in Candida albicans is driven by long repeat sequences","volume":"8","author":"Todd","year":"2019","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib24","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/jac\/dky270","article-title":"Trends in antifungal use in US hospitals, 2006-12","volume":"73","author":"Vallabhaneni","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.003_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.idc.2021.03.003_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2021.03.003_bib30","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib31","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","article-title":"Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains","volume":"42","author":"Franz","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 10","key":"10.1016\/j.idc.2021.03.003_bib32","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans","volume":"145","author":"Marichal","year":"1999","journal-title":"Microbiology (Reading)"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5785","key":"10.1016\/j.idc.2021.03.003_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2958.2008.06176.x","article-title":"An isochromosome confers drug resistance in\u00a0vivo by amplification of two genes, ERG11 and TAC1","volume":"68","author":"Selmecki","year":"2008","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib36","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschhauser","year":"2007","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib37","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot Cell"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib38","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib39","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot Cell"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib40","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/EC.00327-07","article-title":"Genome-wide expression and location analyses of the Candida albicans Tac1p regulon","volume":"6","author":"Liu","year":"2007","journal-title":"Eukaryot Cell"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib41","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1128\/AAC.48.8.3064-3079.2004","article-title":"Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters","volume":"48","author":"Karababa","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib42","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/AAC.49.7.2785-2792.2005","article-title":"Drug-induced regulation of the MDR1 promoter in Candida albicans","volume":"49","author":"Harry","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib43","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","article-title":"Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes","volume":"49","author":"MacPherson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.42.2.241","article-title":"Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents","volume":"42","author":"Sanglard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","article-title":"Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains","volume":"69","author":"Dunkel","year":"2008","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib48","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.clinthera.2005.08.007","article-title":"A\u00a0retrospective evaluation of fluconazole for the treatment of Candida glabrata fungemia","volume":"27","author":"Wilson","year":"2005","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib49","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib50","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","article-title":"Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.49.2.783-787.2005","article-title":"Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole","volume":"49","author":"Borst","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib52","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib53","doi-asserted-by":"crossref","first-page":"e1000268","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.idc.2021.03.003_bib54","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fmicb.2016.00526","article-title":"Clotrimazole drug resistance in Candida glabrata clinical isolates correlates with increased expression of the drug:H(+) Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2","volume":"7","author":"Costa","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.idc.2021.03.003_bib55","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1038\/ncomms11128","article-title":"Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance","volume":"7","author":"Healey","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/AAC.00195-18","article-title":"Absence of Azole or Echinocandin Resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in the DNA mismatch repair pathway","volume":"62","author":"Singh","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/AAC.01876-18","article-title":"MSH2 gene point mutations are not antifungal resistance markers in Candida glabrata","volume":"63","author":"Bordallo-Cardona","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib58","doi-asserted-by":"crossref","first-page":"e00153-18","DOI":"10.1128\/AAC.00153-18","article-title":"Profiling of PDR1 and MSH2 in Candida glabrata bloodstream isolates from a multicenter study in China","volume":"62","author":"Hou","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib59","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1128\/AAC.44.9.2411-2418.2000","article-title":"Depletion of the squalene synthase (ERG9) gene does not impair growth of Candida glabrata in mice","volume":"44","author":"Nakayama","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib60","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkm321","article-title":"The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum","volume":"60","author":"Nakayama","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib61","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/EC.00345-12","article-title":"Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae","volume":"12","author":"Zavrel","year":"2013","journal-title":"Eukaryot Cell"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1099\/00222615-48-7-663","article-title":"In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata","volume":"48","author":"Defontaine","year":"1999","journal-title":"J\u00a0Med Microbiol"},{"issue":"3873","key":"10.1016\/j.idc.2021.03.003_bib63","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.163.3873.1331","article-title":"Cytoplasmic DNA from petite colonies of Saccharomyces cerevisiae: a hypothesis on the nature of the mutation","volume":"163","author":"Carnevali","year":"1969","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/46.2.191","article-title":"Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae","volume":"46","author":"Kontoyiannis","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib65","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01271-10","article-title":"Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice","volume":"55","author":"Ferrari","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib66","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.48.5.1788-1796.2004","article-title":"Mechanisms of azole resistance in petite mutants of Candida glabrata","volume":"48","author":"Brun","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00294-008-0187-9","article-title":"Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata","volume":"53","author":"Batova","year":"2008","journal-title":"Curr Genet"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib68","doi-asserted-by":"crossref","first-page":"e63393","DOI":"10.1371\/journal.pone.0063393","article-title":"Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AAC.50.2.744-747.2006","article-title":"Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin","volume":"50","author":"Chamilos","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.003_bib70","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib71","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa","volume":"71","author":"Govender","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2021.03.003_bib72","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3389\/fmicb.2018.02997","article-title":"An azole-resistant candida parapsilosis outbreak: clonal persistence in the intensive care unit of a Brazilian teaching hospital","volume":"9","author":"Thomaz","year":"2018","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib73","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jac\/dkz029","article-title":"Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India","volume":"74","author":"Singh","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.01001-20","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib75","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3201\/eid2409.180625","article-title":"Fluconazole-resistant Candida parapsilosis bloodstream isolates with Y132F mutation in ERG11 Gene, South Korea","volume":"24","author":"Choi","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib76","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1128\/AAC.01358-15","article-title":"Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis","volume":"59","author":"Berkow","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib77","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/AAC.00842-15","article-title":"Fluconazole and Voriconazole Resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene","volume":"59","author":"Branco","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib78","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2003.09.008","article-title":"In\u00a0vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program","volume":"48","author":"Pfaller","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/mSphere.00821-20","article-title":"Triazole evolution of Candida parapsilosis results in cross-resistance to other antifungal drugs, influences stress responses, and alters virulence in an antifungal drug-dependent manner","volume":"5","author":"Papp","year":"2020","journal-title":"mSphere"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib81","first-page":"285","article-title":"Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina","volume":"29","author":"Vigezzi","year":"2019","journal-title":"J\u00a0Mycol Med"},{"key":"10.1016\/j.idc.2021.03.003_bib82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fcimb.2019.00264","article-title":"Molecular identification, genotypic diversity, antifungal susceptibility, and clinical outcomes of infections caused by clinically underrated yeasts, Candida orthopsilosis, and Candida metapsilosis: an Iranian multicenter study (2014-2019)","volume":"9","author":"Arastehfar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib83","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dky122","article-title":"CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates","volume":"73","author":"Rizzato","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2021.03.003_bib84","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/1469-0691.12004","article-title":"Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel","volume":"19","author":"Ben-Ami","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib85","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","article-title":"Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei","volume":"39","author":"Katiyar","year":"2001","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib86","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13693780600561544","article-title":"Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps","volume":"44","author":"Guinea","year":"2006","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib87","doi-asserted-by":"crossref","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib88","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/infdis\/jix597","article-title":"The Candida auris alert: facts and perspectives","volume":"217","author":"Lamoth","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib89","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dkx480","article-title":"A\u00a0multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance","volume":"73","author":"Chowdhary","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib90","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.00367-15","volume":"53","author":"Kathuria","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib91","doi-asserted-by":"crossref","first-page":"e0223433","DOI":"10.1371\/journal.pone.0223433","article-title":"Clade II Candida auris possess genomic structural variations related to an ancestral strain","volume":"14","author":"Sekizuka","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib92","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12864-015-1863-z","article-title":"Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris","volume":"16","author":"Chatterjee","year":"2015","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib93","doi-asserted-by":"crossref","first-page":"e00722-15","DOI":"10.1128\/genomeA.00722-15","article-title":"Draft genome sequence of a fluconazole-resistant Candida auris strain from a Candidemia patient in India","volume":"3","author":"Sharma","year":"2015","journal-title":"Genome Announc"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib94","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1038\/s41598-019-41513-6","article-title":"Gene duplication associated with increased fluconazole tolerance in Candida auris cells of advanced generational age","volume":"9","author":"Bhattacharya","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib95","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3201\/eid1910.130393","article-title":"New clonal strain of Candida auris, Delhi, India","volume":"19","author":"Chowdhary","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib96","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","author":"Chowdhary","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib97","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jac\/dkx034","article-title":"Candida auris candidaemia in Indian ICUs: analysis of risk factors","volume":"72","author":"Rudramurthy","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2021.03.003_bib98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/mmy\/myaa005","article-title":"Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts","volume":"58","author":"Stavrou","year":"2020","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib99","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41598-017-01106-7","article-title":"Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.idc.2021.03.003_bib100","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"Segal","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib101","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib102","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JCM.01070-09","article-title":"Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Balajee","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5\u20136","key":"10.1016\/j.idc.2021.03.003_bib103","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-resistant aspergillosis due to cryptic species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In\u00a0vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","author":"Alastruey-Izquierdo","year":"2010","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/TP.0b013e31825992f0","article-title":"Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis","volume":"94","author":"Egli","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/EC.4.3.625-632.2005","article-title":"Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus","volume":"4","author":"Balajee","year":"2005","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.idc.2021.03.003_bib107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.01374-20","article-title":"Multicentric analysis of the species distribution and antifungal susceptibility of cryptic isolates from Aspergillus section Fumigati","volume":"64","author":"Imbert","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/AAC.00632-19","article-title":"cyp51A mutations, extrolite profiles, and antifungal susceptibility in clinical and environmental isolates of the Aspergillus viridinutans Species Complex","volume":"63","author":"Talbot","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib109","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","article-title":"Cryptic species and azole resistance in the Aspergillus niger complex","volume":"55","author":"Howard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2021.03.003_bib110","article-title":"Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study","volume":"10","author":"Glampedakis","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib111","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/AAC.00316-10","article-title":"Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B","volume":"54","author":"Warrilow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib112","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fgb.2011.08.002","article-title":"The structure-function relationship of the Aspergillus fumigatuscyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance","volume":"48","author":"Snelders","year":"2011","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.idc.2021.03.003_bib113","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype-phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet Biol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib114","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib115","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A\u00a0new Aspergillus fumigatus resistance mechanism conferring in\u00a0vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib116","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib117","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib118","first-page":"67","article-title":"High-frequency direct detection of triazole resistance in Aspergillus fumigatus from patients with chronic pulmonary fungal diseases in India","volume":"6","author":"Singh","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib119","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid2410.180730","article-title":"Non-cyp51A azole-resistant Aspergillus fumigatus isolates with mutation in HMG-CoA reductase","volume":"24","author":"Hagiwara","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fgb.2019.05.005","article-title":"Recreation of in-host acquired single nucleotide polymorphisms by CRISPR-Cas9 reveals an uncharacterised gene playing a role in Aspergillus fumigatus azole resistance via a non-cyp51A mediated resistance mechanism","volume":"130","author":"Ballard","year":"2019","journal-title":"Fungal Genet Biol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib121","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.49.2.518-524.2005","article-title":"Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors","volume":"49","author":"Xiong","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib122","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib123","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib124","first-page":"8","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib125","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diagmicrobio.2011.07.007","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib127","doi-asserted-by":"crossref","first-page":"e00166-17","DOI":"10.1128\/mBio.00166-17","article-title":"Microevolution of serial clinical isolates of cryptococcus neoformans var. grubii and C. gattii","volume":"8","author":"Chen","year":"2017","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib128","first-page":"378","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis","volume":"100","author":"Jarvis","year":"2010","journal-title":"S\u00a0Afr Med J"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A\u00a0systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.03.003_bib130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2334-12-361","article-title":"Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib131","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal Combinations for treatment of Cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib132","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12543","article-title":"Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain","volume":"60","author":"Gago","year":"2017","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib133","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 6","key":"10.1016\/j.idc.2021.03.003_bib134","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib136","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib137","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib138","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3201\/eid2011.140685","article-title":"Drug-resistant Candida glabrata infection in cancer patients","volume":"20","author":"Farmakiotis","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib139","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.00443-09","article-title":"Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint","volume":"53","author":"Garcia-Effron","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"Perlin","year":"2007","journal-title":"Drug Resist Updat"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib141","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/AAC.50.4.1148-1155.2006","article-title":"Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility","volume":"50","author":"Niimi","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib142","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/JCM.40.6.2228-2230.2002","article-title":"In\u00a0vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance","volume":"40","author":"Bachmann","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib143","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/JCM.41.12.5729-5731.2003","article-title":"Caspofungin activity against clinical isolates of fluconazole-resistant Candida","volume":"41","author":"Pfaller","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib144","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"10.1016\/j.idc.2021.03.003_bib145","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1073\/pnas.91.26.12907","article-title":"The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase","volume":"91","author":"Douglas","year":"1994","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib146","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/iai.64.8.3244-3251.1996","article-title":"Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies","volume":"64","author":"Kurtz","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib147","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib148","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.06369-11","article-title":"Differential in\u00a0vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations","volume":"56","author":"Arendrup","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib149","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1128\/AAC.00538-06","article-title":"In\u00a0vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility","volume":"50","author":"Cota","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib150","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/AAC.01750-10","article-title":"Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans","volume":"55","author":"Wiederhold","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.003_bib151","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1080\/13693780400029023","article-title":"Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin","volume":"43","author":"Gardiner","year":"2005","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib152","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/AAC.00917-07","article-title":"A\u00a0Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus","volume":"51","author":"Rocha","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib153","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acscentsci.0c00813","article-title":"Elevated vacuolar uptake of fluorescently labeled antifungal drug caspofungin predicts echinocandin resistance in pathogenic yeast","volume":"6","author":"Jaber","year":"2020","journal-title":"ACS Cent Sci"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib154","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.02037-12","article-title":"Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin","volume":"57","author":"Fekkar","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib155","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/AAC.00473-08","article-title":"Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection","volume":"52","author":"Thompson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib156","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/AAC.48.4.1382-1383.2004","article-title":"Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis","volume":"48","author":"Hernandez","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib157","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/dkl022","article-title":"Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis","volume":"57","author":"Laverdi\u00e8re","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib158","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1592\/phco.26.6.877","article-title":"Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin","volume":"26","author":"Miller","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib159","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/AAC.00802-08","article-title":"Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies","volume":"52","author":"Garcia-Effron","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib161","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1086\/500939","article-title":"Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient","volume":"42","author":"Krogh-Madsen","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib162","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib163","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/AAC.01144-13","article-title":"Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure","volume":"57","author":"Lewis","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib164","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib165","doi-asserted-by":"crossref","first-page":"e1002718","DOI":"10.1371\/journal.ppat.1002718","article-title":"Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata","volume":"8","author":"Singh-Babak","year":"2012","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib166","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/EC.00310-10","article-title":"Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis","volume":"10","author":"Chen","year":"2011","journal-title":"Eukaryot Cell"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib167","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/jit530","article-title":"Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatus","volume":"209","author":"Lamoth","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib168","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1038\/s41598-019-45817-5","article-title":"The fungal histone acetyl transferase Gcn5 controls virulence of the human pathogen Candida albicans through multiple pathways","volume":"9","author":"Shivarathri","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib169","doi-asserted-by":"crossref","first-page":"e01584-20","DOI":"10.1128\/AAC.01584-20","article-title":"Efg1 and Cas5 orchestrate cell wall damage response to Caspofungin in Candida albicans","volume":"65","author":"Xiong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib170","doi-asserted-by":"crossref","first-page":"ofz262","DOI":"10.1093\/ofid\/ofz262","article-title":"Development of high-level echinocandin resistance in a patient with recurrent Candida auris Candidemia Secondary to Chronic Candiduria","volume":"6","author":"Biagi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib171","doi-asserted-by":"crossref","first-page":"e00238-18","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding echinocandin resistance in the emerging pathogen Candida auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib172","doi-asserted-by":"crossref","first-page":"e00973-20","DOI":"10.1128\/mSphere.00973-20","article-title":"The two-component response regulator Ssk1 and the mitogen-activated protein kinase Hog1 control antifungal drug resistance and cell wall architecture of Candida auris","volume":"5","author":"Shivarathri","year":"2020","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib173","doi-asserted-by":"crossref","first-page":"e00779-19","DOI":"10.1128\/mBio.00779-19","article-title":"Stress-induced changes in the lipid microenvironment of \u03b2-(1,3)-d-glucan synthase cause clinically important echinocandin resistance in Aspergillus fumigatus","volume":"10","author":"Satish","year":"2019","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib174","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib175","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/EC.00030-06","article-title":"FsFKS1, the 1,3-beta-glucan synthase from the caspofungin-resistant fungus Fusarium solani","volume":"5","author":"Ha","year":"2006","journal-title":"Eukaryot Cell"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib176","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15698\/mic2020.04.714","article-title":"More than flipping the lid: Cdc50 contributes to echinocandin resistance by regulating calcium homeostasis in Cryptococcus neoformans","volume":"7","author":"Cao","year":"2020","journal-title":"Microb Cell"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib177","doi-asserted-by":"crossref","first-page":"e01952-19","DOI":"10.1128\/mBio.01952-19","article-title":"A\u00a0Mechanosensitive channel governs lipid flippase-mediated echinocandin resistance in Cryptococcus neoformans","volume":"10","author":"Cao","year":"2019","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib178","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1128\/AAC.46.11.3394-3400.2002","article-title":"Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin","volume":"46","author":"van Duin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.003_bib179","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib181","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13693780801968571","article-title":"Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome","volume":"46","author":"Atkinson","year":"2008","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.idc.2021.03.003_bib182","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","article-title":"Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents","volume":"47","author":"Sanglard","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib183","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A\u00a0clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib184","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciy411","article-title":"Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in Amphotericin B resistance","volume":"68","author":"Escandon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib185","doi-asserted-by":"crossref","first-page":"40232","DOI":"10.1038\/srep40232","article-title":"Transcriptome and network analyses in Saccharomyces cerevisiae reveal that amphotericin B and lactoferrin synergy disrupt metal homeostasis and stress response","volume":"7","author":"Pang","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib186","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.02130-13","article-title":"Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance","volume":"58","author":"Sharma","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib187","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","article-title":"Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae","volume":"47","author":"Young","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib188","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1128\/AAC.01283-12","article-title":"New insight into amphotericin B resistance in Aspergillus terreus","volume":"57","author":"Blum","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl_1","key":"10.1016\/j.idc.2021.03.003_bib189","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/mmy\/myx119","article-title":"Aspergillus terreus: novel lessons learned on amphotericin B resistance","volume":"56","author":"Posch","year":"2018","journal-title":"Med Mycol"},{"issue":"7\u20138","key":"10.1016\/j.idc.2021.03.003_bib190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1439-0507.2000.00587.x","article-title":"Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans","volume":"43","author":"Fekete-Forg\u00e1cs","year":"2000","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib191","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1128\/AAC.42.11.2938","article-title":"Fluconazole versus Candida albicans: a complex relationship","volume":"42","author":"Graybill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib192","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1128\/AAC.01223-07","article-title":"Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans","volume":"52","author":"Angiolella","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib193","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/JB.183.10.2971-2978.2001","article-title":"Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans","volume":"183","author":"Cowen","year":"2001","journal-title":"J\u00a0Bacteriol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib194","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2958.2012.08210.x","article-title":"The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans","volume":"86","author":"Sasse","year":"2012","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib195","doi-asserted-by":"crossref","first-page":"fov025","DOI":"10.1093\/femsyr\/fov025","article-title":"Tipping the balance both ways: drug resistance and virulence in Candida glabrata","volume":"15","author":"Vale-Silva","year":"2015","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib196","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/jir351","article-title":"Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance","volume":"204","author":"Ben-Ami","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib197","first-page":"32","article-title":"Antifungal resistance does not necessarily affect Candida glabrata fitness","volume":"26","author":"Borghi","year":"2014","journal-title":"J\u00a0Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib198","doi-asserted-by":"crossref","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"Vincent","year":"2013","journal-title":"PLoS Biol"},{"issue":"24","key":"10.1016\/j.idc.2021.03.003_bib199","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib200","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajic.2010.02.016","article-title":"Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections","volume":"38","author":"Lee","year":"2010","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.idc.2021.03.003_bib202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib203","first-page":"21","article-title":"Contributions of the biofilm matrix to Candida pathogenesis","volume":"6","author":"Nett","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib204","doi-asserted-by":"crossref","first-page":"e00655-16","DOI":"10.1128\/mBio.00655-16","article-title":"Heteroresistance to fluconazole is a continuously distributed phenotype among Candida glabrata clinical strains associated with in\u00a0vivo persistence","volume":"7","author":"Ben-Ami","year":"2016","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib205","doi-asserted-by":"crossref","first-page":"e1004211","DOI":"10.1371\/journal.ppat.1004211","article-title":"Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes","volume":"10","author":"Schwarzmuller","year":"2014","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib206","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/AAC.00095-07","article-title":"Paradoxical effect of Echinocandins across Candida species in\u00a0vitro: evidence for echinocandin-specific and candida species-related differences","volume":"51","author":"Chamilos","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.003_bib207","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib208","first-page":"192","article-title":"The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen","volume":"54","author":"Morschhauser","year":"2016","journal-title":"J\u00a0Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib209","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cix297","article-title":"Changes in in\u00a0vitro susceptibility patterns of Aspergillus to Triazoles and correlation with aspergillosis outcome in a Tertiary Care Cancer Center, 1999-2015","volume":"65","author":"Heo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib210","doi-asserted-by":"crossref","first-page":"e00662","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of Candida albicans","volume":"4","author":"Ford","year":"2015","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib211","doi-asserted-by":"crossref","first-page":"e00536","DOI":"10.1128\/mBio.00536-15","article-title":"Genomic context of azole resistance mutations in aspergillus fumigatus determined using whole-genome sequencing","volume":"6","author":"Abdolrasouli","year":"2015","journal-title":"mBio"},{"issue":"24","key":"10.1016\/j.idc.2021.03.003_bib212","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"suppl_3","key":"10.1016\/j.idc.2021.03.003_bib213","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1093\/infdis\/jix222","article-title":"Animal models for studying triazole resistance in aspergillus fumigatus","volume":"216","author":"Lewis","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib214","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1473-3099(06)70686-7","article-title":"Role of mini-host models in the study of medically important fungi","volume":"7","author":"Chamilos","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4161\/viru.20746","article-title":"The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida","volume":"3","author":"Lewis","year":"2012","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib216","doi-asserted-by":"crossref","first-page":"e12955","DOI":"10.1371\/journal.pone.0012955","article-title":"Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses","volume":"5","author":"Chamilos","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib217","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589290","article-title":"Immunocompromised hosts: immunopharmacology of modern antifungals","volume":"47","author":"Ben-Ami","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib218","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.idc.2021.03.003_bib219","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QCO.0b013e3283321ce5","article-title":"Antifungal drug resistance: do molecular methods provide a way forward?","volume":"22","author":"Perlin","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.003_bib220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","article-title":"MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis","volume":"6","author":"Singhal","year":"2015","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib221","doi-asserted-by":"crossref","first-page":"e01244-19","DOI":"10.1128\/AAC.01244-19","article-title":"Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients","volume":"63","author":"Lamoth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.003_bib222","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1592\/phco.2005.25.9.1174","article-title":"Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in\u00a0vitro susceptibility data and the outcome of initial amphotericin B therapy","volume":"25","author":"Lionakis","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.idc.2021.03.003_bib223","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in\u00a0vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.idc.2021.03.003_bib224","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/dkaa446","article-title":"Knowledge gaps in candidaemia\/invasive candidiasis in haematological cancer patients","volume":"76","author":"Colombo","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.003_bib225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"issue":"10","key":"10.1016\/j.idc.2021.03.003_bib226","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib227","doi-asserted-by":"crossref","first-page":"a019737","DOI":"10.1101\/cshperspect.a019737","article-title":"Treatment principles for the management of mold infections","volume":"5","author":"Kontoyiannis","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib228","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib229","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.003_bib230","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cid\/cit140","article-title":"Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida","volume":"56","author":"Ostrosky-Zeichner","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9312","key":"10.1016\/j.idc.2021.03.003_bib231","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2021.03.003_bib232","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06795.x","article-title":"The impact of azole resistance on aspergillosis guidelines","volume":"1272","author":"Georgiadou","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.idc.2021.03.003_bib233","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myw060","article-title":"The anti-Aspergillus drug pipeline: is the glass half full or empty?","volume":"55","author":"Osherov","year":"2017","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.003_bib234","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.201344405","article-title":"The bacteriome-mycobiome interaction and antifungal host defense","volume":"44","author":"Oever","year":"2014","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.003_bib235","doi-asserted-by":"crossref","first-page":"e1008353","DOI":"10.1371\/journal.ppat.1008353","article-title":"The gut mycobiome: the overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions","volume":"16","author":"Galloway-Pe\u00f1a","year":"2020","journal-title":"PLoS Pathog"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:28:20Z","timestamp":1760196500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552021000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":235,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0891552021000131"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.003","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to Antifungal Drugs","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}